Huasun(SZ:000790)2024-02-02 11:21Group 1: Investment and Acquisition Strategy - The company aims to solidify its core business through both organic growth and external acquisitions, focusing on products or technologies that align with its pharmaceutical health strategy [1] - The goal is to enhance the quality of acquisition targets and improve revenue structure by integrating industry resources [1] Group 2: Product Pricing and Market Strategy - Product pricing is determined by multiple factors including cost, competitive landscape, brand influence, and consumer acceptance, with adjustments made in response to market demand [2] - The company is actively restructuring its marketing system to improve operational efficiency in 2024, focusing on team building, product-market strategies, and brand promotion [2] Group 3: Sales Expectations and Future Outlook - The company emphasizes the importance of its sales team and market potential, with expectations for improved sales efficiency in 2024 [2] - In 2024, the company plans to leverage opportunities in the pharmaceutical health industry, optimize operational strategies, and enhance product development [2] Group 4: Core Products and Health Business Layout - Core products include over 30 varieties such as Sanqi Tongshu Capsules and Biyuan Shuqing Oral Liquid [2] - The company is focused on expanding its health product offerings, including high-end bottled beverages and health energy drinks, to increase market share [2]